Free Newsletter
Justice probes biliary stent marketing
The U.S. Department of Justice has launched a probe of the bile-duct stent market, trying to determine whether companies such as Abbott Laboratories, Boston Scientific and Johnson & Johnson improperly promoted the devices. The U.S. Attorney's Office in Massachusetts has been subpoenaing stentmakers about their marketing practices, according to SEC filings. The companies have reported that Justice wants to know whether they've promoted the biliary stents for other uses, such as propping open leg arteries.
The U.S. Attorney's office wouldn't comment on the investigation, and the companies themselves wouldn't either, beyond saying that they're cooperating.
- read the Dow Jones story at CNN Money
Related Articles:
Supreme Court shields device makers
FDA flubs off-label enforcement
Comments
By Anonymous | Posted 11:56am | November 10, 2008
My husband was used as a test subject without knowing it. He was implanted with a biliary stent in his leg and died as a result.
By Anonymous | Posted 5:00pm | February 20, 2010
Would you like for the specific manufacturer to have to address his death. Many of such serious losses may have been concealed from federal authorities. Contact me, if you want to follow up on your post.
Post new comment
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
SHARE
WITH: